首页> 外文期刊>Clinical and diagnostic laboratory immunology >T-Helper-Cell Proliferative Responses to Whole-Killed Human Immunodeficiency Virus Type 1 (HIV-1) and p24 Antigens of Different Clades in HIV-1-Infected Subjects Vaccinated with HIV-1 Immunogen (Remune)
【24h】

T-Helper-Cell Proliferative Responses to Whole-Killed Human Immunodeficiency Virus Type 1 (HIV-1) and p24 Antigens of Different Clades in HIV-1-Infected Subjects Vaccinated with HIV-1 Immunogen (Remune)

机译:T型辅助细胞对全杀灭的人类免疫缺陷病毒1型(HIV-1)和不同支系的p24抗原在感染了HIV-1免疫原的HIV-1感染者中的免疫应答(免疫)

获取原文
           

摘要

The discovery of multiple subtypes of human immunodeficiency virus type 1 (HIV-1) worldwide has created new challenges for the development of both therapeutic and preventive AIDS vaccines. We examined T-helper proliferative responses to HIV-1 clade A, B, C, G, and E whole-killed virus and to HIV-1 clade G and B core (p24) antigens in HIV-1-infected subjects taking potent antiviral drugs who received HIV immunogen (Remune) therapeutic vaccination. Subjects who were immunized mounted strong proliferative responses to both whole virus and core antigens of the different clades. These results suggest that a whole-killed immunogen may have broad applications as a therapeutic as well as a preventive vaccine in the current multiclade HIV-1 pandemic.
机译:全世界人类免疫缺陷病毒1型(HIV-1)多种亚型的发现为治疗性和预防性AIDS疫苗的开发提出了新的挑战。我们在接受强效抗病毒治疗的HIV-1感染者中检查了对HIV-1进化枝A,B,C,G和E全杀病毒以及对HIV-1进化枝G和B核心(p24)抗原的T辅助细胞增殖反应。接受HIV免疫原(Remune)治疗性疫苗接种的药物。免疫的受试者对全病毒和不同进化枝的核心抗原都表现出强烈的增殖反应。这些结果表明,在当前的多群HIV-1大流行中,一种完全杀死的免疫原可能作为治疗性疫苗和预防性疫苗具有广泛的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号